Edwards Lifesciences Corporation (EW)
NYSE: EW · IEX Real-Time Price · USD
89.19
+0.05 (0.06%)
May 20, 2024, 9:35 AM EDT - Market open
Edwards Lifesciences Revenue
Edwards Lifesciences had revenue of $6.14B in the twelve months ending March 31, 2024, with 11.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.60B with 9.50% year-over-year growth. In the year 2023, Edwards Lifesciences had annual revenue of $6.00B with 11.56% growth.
Revenue (ttm)
$6.14B
Revenue Growth
+11.68%
P/S Ratio
8.74
Revenue / Employee
$310,273
Employees
19,800
Market Cap
53.63B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.00B | 622.40M | 11.56% |
| Dec 31, 2022 | 5.38B | 149.90M | 2.86% |
| Dec 31, 2021 | 5.23B | 846.20M | 19.29% |
| Dec 31, 2020 | 4.39B | 38.30M | 0.88% |
| Dec 31, 2019 | 4.35B | 625.20M | 16.79% |
| Dec 31, 2018 | 3.72B | 287.50M | 8.37% |
| Dec 31, 2017 | 3.44B | 471.60M | 15.91% |
| Dec 31, 2016 | 2.96B | 470.00M | 18.85% |
| Dec 31, 2015 | 2.49B | 170.80M | 7.35% |
| Dec 31, 2014 | 2.32B | 277.40M | 13.56% |
| Dec 31, 2013 | 2.05B | 145.90M | 7.68% |
| Dec 31, 2012 | 1.90B | 221.00M | 13.17% |
| Dec 31, 2011 | 1.68B | 231.60M | 16.01% |
| Dec 31, 2010 | 1.45B | 125.60M | 9.51% |
| Dec 31, 2009 | 1.32B | 83.70M | 6.76% |
| Dec 31, 2008 | 1.24B | 146.60M | 13.44% |
| Dec 31, 2007 | 1.09B | 54.10M | 5.22% |
| Dec 31, 2006 | 1.04B | 39.10M | 3.92% |
| Dec 31, 2005 | 997.90M | 66.40M | 7.13% |
| Dec 31, 2004 | 931.50M | 71.00M | 8.25% |
| Dec 31, 2003 | 860.50M | 156.50M | 22.23% |
| Dec 31, 2002 | 704.00M | 11.90M | 1.72% |
| Dec 31, 2001 | 692.10M | -111.70M | -13.90% |
| Dec 31, 2000 | 803.80M | -101.20M | -11.18% |
| Dec 31, 1999 | 905.00M | 40.00M | 4.62% |
| Dec 31, 1998 | 865.00M | -14.00M | -1.59% |
| Dec 31, 1997 | 879.00M | 42.00M | 5.02% |
| Dec 31, 1996 | 837.00M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 360.94B |
| McKesson | 308.95B |
| Cencora | 276.54B |
| Gilead Sciences | 27.45B |
| Becton, Dickinson and Company | 19.72B |
| Zoetis | 8.73B |
| Agilent Technologies | 6.74B |
| Moderna | 5.15B |
EW News
- 6 days ago - Edwards Lifesciences hit with Meril's EU antitrust complaint - Reuters
- 11 days ago - Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability - Business Wire
- 24 days ago - Edwards Lifesciences first-quarter profit beats estimates on heart devices strength - Reuters
- 24 days ago - Edwards Lifesciences Reports First Quarter Results - Business Wire
- 4 weeks ago - Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024 - Business Wire
- 5 weeks ago - This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? - Market Watch
- 6 weeks ago - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It - Business Wire
- 2 months ago - Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR - Business Wire